Brightsurf Science News and Current Science News Events
 

Multiple Sclerosis Therapy News | Multiple Sclerosis Therapy Current Events
Page 1 of 53 | 1322 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Sun exposure seems to reduce risk of multiple sclerosis
Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis, finds a study in this week's BMJ. Multiple sclerosis is more common at higher latitudes, which generally have lower levels of ultraviolet radiation. The study was carried out in... view more (2003-08-06)

Ultra-high-field MRI allows for earlier diagnosis of multiple sclerosis
Ultra-high-field (7T) MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment.   view more (2007-05-07)

Stress makes MS symptoms worse
For patients with multiple sclerosis, stressful life events seem to make their symptoms worse, finds a study in this week’s BMJ.   view more (2003-09-17)

BUDGET FOR INTERFERON BETA FOR MS SUFFERERS WOULD BE BETTER SPENT ON IMPROVED SUPPORTIVE CARE
Dr Raeburn Forbes from Ninewells Hospital and Medical School in Dundee along with colleagues from Argyll and Clyde Health Board and the Scottish Health Purchasing Information Centre studied 132 people with secondary progressive multiple sclerosis and the estimated effect of treating them with... view more (1999-12-08)

Detection Of Antibodies Could Identify MS Patients Who Do Not Respond Well To Interferon Beta (P1184)
Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the... view more (2003-10-08)

Government money for multiple sclerosis patients could be better spent
The National Institute for Clinical Excellence (NICE) has announced that neither interferon beta nor glatiramer can be recommended for multiple sclerosis in the NHS. However, the UK government plans to make these drugs available through a risk sharing scheme, despite limited evidence of clinical... view more (2003-02-12)

New imaging technique could promote early detection of multiple sclerosis
Researchers from Purdue University have studied and recorded how myelin degrades real-time in live mice using a new imaging technique. Myelin is the fatty sheath coating the axons, or nerve cells, that insulate and aid in efficient nerve fiber conduction. In diseases such as multiple sclerosis, the... view more (2007-06-28)

Questions over accuracy of MRI in diagnosing multiple sclerosis
The accuracy of magnetic resonance imaging (MRI) is not sufficient to rule in or rule out a diagnosis of MS with a high degree of certainty, finds a study published online by the BMJ today.   view more (2006-03-24)

Occupational exposure to anaesthetic gases associated with tripling of risk of multiple sclerosis
Occupational exposure to anaesthetic gases may triple the risk of multiple sclerosis, finds a study of nurses in Occupational and Environmental Medicine.   view more (2002-12-17)

Patients' views about their illness can help treatment planning
What is it like to be chronically ill? Those people with severe illnesses such as Huntington's disease or multiple sclerosis do not see their illness in the same way as health professionals do. Associate professor Ad Kaptein, Leiden University, Netherlands organised an international symposium on... view more (2001-08-31)

Further evidence showing treatment benefits of beta interferon for multiple sclerosis (pp 1463, 1489)
Results of a European study in this week's issue of THE LANCET provide further evidence that patients with early symptoms of multiple sclerosis given a weekly injection with interferon beta are less likely to progress to full clinical disease after two years follow-up. The study showed that the... view more (2004-10-20)

Genes influence both susceptibility to, and progression of, multiple sclerosis
Susceptibility to multiple sclerosis (MS), and the way in which the disease progresses, are genetically determined, suggests research in the Journal of Neurology Neurosurgery and Psychiatry.   view more (2001-11-23)

Treating MS is expensive, but cost falls over time
The cost of drug treatment multiple sclerosis is high, but decreases with prolonged treatment up to 20 years, concludes a study in this week's BMJ. Researchers evaluated the cost effectiveness of four drugs currently licensed for the treatment of multiple sclerosis in the United Kingdom (three... view more (2003-03-05)

Potential new target for multiple sclerosis therapy
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.   view more (2008-03-31)

Milestone for cannabinoid MS study
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.   view more (2008-07-22)

Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients
Defects on cell-surface sugars may promote the short-term inflammation and long-term neurodegeneration that occurs in the central nervous system of multiple sclerosis patients, according to University of California, Irvine researchers.   view more (2007-09-21)

Downstate researchers target multiple sclerosis
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally.   view more (2006-11-22)

Lords Call For Faster Progress Towards Cannabis-Based Medicine
Progress towards a cannabis-based medicine for conditions such as multiple sclerosis is too slow, says the House of Lords Science & Technology Committee in a report published today [22 March]. The use of cannabis for any purpose other than scientific research is currently illegal. In November... view more (2001-03-22)

Essential Hope for Multiple Sclerosis
New research by psychologists reveals the positive effects of aromatherapy on the quality of life for Multiple Sclerosis (MS) sufferers. Researchers at the University of Teeside found MS patients, in spite of experiencing the same symptoms, felt more vitality, happiness and peace during... view more (2004-08-23)

Genetic differences may help explain response to multiple sclerosis treatment
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two.   view more (2008-01-15)

Another hope for multiple sclerosis patients. Improved Interferon-beta patent recently granted by
Blurred vision, weak limbs, tingling sensations, unsteadiness and fa-tigue are the symptoms of one of the most common diseases of the central nervous system, the multiple sclerosis (MS). It is estimated that MS currently affects over 2,500,000 people worldwide. There is new hope for MS patients:... view more (2003-08-06)

May: Multiple Sclerosis Awareness Month -- latest research is good news
May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then by highlighting the latest research that might offer hope for the 55 to 75, 000 sufferers across Canada.   view more (2007-05-03)

Combining multiple treatments improves multiple sclerosis therapy
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS) in which white blood cells known as lymphocytes attack the myelin insulation on nerves in the spinal cord and brain.   view more (2006-03-17)

The Lancet Neurology - January 2003
STROKE IN THE 21st CENTURY In the first issue of 2003, TLN examines stroke epidemiology and stroke trials. In their review, Valery Feigin and co-authors provide an overview of population-based studies of incidence, prevalence, mortality, and case-fatality of stroke based on studies reported between... view more (2002-12-18)

Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
A group of Israeli scientists from the Technion - Israel Institute of Technology, the Weizmann Institute of Science and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis patients to the drug Copaxone.   view more (2007-10-11)
Page 1 of 53 | 1322 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com